Table 3 Adverse events (n = 76).
Adverse events | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|
Leukocytopenia | 24 (31.6%) | 44 (57.9%) | 4 (5.3%) |
Neutropenia | 8 (10.5%) | 37 (48.7%) | 27 (35.5%) |
Anaemia | 24 (31.6%) | 35 (46.1%) | 8 (10.5%) |
Thrombocytopenia | 13 (17.1%) | 12 (15.8%) | 5 (6.6%) |
Fatigue | 8 (10.5%) | 1 (1.3%) | – |
Anorexia | 11 (14.5%) | 2 (2.6%) | – |
Nausea | 21 (27.6%) | 2 (2.6%) | – |
Vomiting | 13 (17.1%) | - | – |
Constipation | 26 (34.2%) | 2 (2.6%) | – |
Diarrhoea | 5 (6.6%) | - | – |
Neuropathy (sensory) | 15 (19.7%) | 6 (7.9%) | – |
Neuropathy (motor) | 12 (15.8%) | 2 (2.6%) | – |
Arthralgia | 4 (5.3%) | 1 (1.3%) | – |
Myalgia | 4 (5.3%) | 1 (1.3%) | – |
Alopecia | 46 (60.5%) | - | – |
Thrombosis | – | 1 (1.3%) | 1 (1.3%) |
Port-related adverse events | – | 9 (11.8%) | – |
